Eri Kawata

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

Shinya Kimura, Haruna Naito, Hidekazu Segawa et al. · Blood · 2005 · 243 citations · Full text

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia

Masahiro Sakaguchi, Hiroki Yamaguchi, Yuho Najima et al. · Blood Advances · 2018 · 128 citations · Full text

Prognostic impact of <i>CEBPA</i> bZIP domain mutation in acute myeloid leukemia

Satoshi Wakita, Masahiro Sakaguchi, Iekuni Oh et al. · Blood Advances · 2021 · 116 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Favorable Prognosis +16

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity

Asumi Yokota, Shinya Kimura, Satohiro Masuda et al. · Blood · 2006 · 102 citations · Full text

ABT‐737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug‐resistance mechanisms

Junya Kuroda, Shinya Kimura, Michael Andreeff et al. · British Journal of Haematology · 2007 · 83 citations · Full text